Latest Monocyte Stories
A new study by LMU researchers led by Christian Weber sheds light on the role of the adhesion molecule JAM-A in the recruitment of immune cells to the inner layer of arteries – which promotes the development of atherosclerosis.
The growth of deadly plaque inside the walls of arteries may not happen as scientists believed.
New insights into the development of vulnerable atherosclerotic plaques could lead to better treatment or prevention of heart attacks and strokes.
New test mimics artery conditions, detects inflammatory cells linked with atherosclerosis and myocardial infarction. SACRAMENTO, Calif.
Currently, most white blood cell counts are performed with large-scale equipment in central clinical laboratories. But now engineers have developed a portable device to count white blood cells that needs less than a pinprick's worth of blood and takes just minutes to run.
LMU researchers led by Christian Weber have, for the first time, elucidated how cells that promote the development of atherosclerosis find their way to the blood vessel wall, where they stimulate the formation of obstructive deposits.
Researchers from Brigham and Women's Hospital (BWH) are the first to discover that changes in monocytes (a type of white blood cell) are a biomarker for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.
Amyotrophic lateral sclerosis (ALS) is a progressive disease wherein the cells of the central nervous system (CNS) involved in movement and coordination are destroyed.
Scientists at the University of East Anglia (UEA) have discovered a 'constant cloud' of potent inflammatory molecules surrounding the cells responsible for diseases such as thickening of the arteries and rheumatoid arthritis.
- Growing in low tufty patches.